Volume 164, Issue 1 p. 82-86
Special Section on COVID-19

Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell

Luca D’Ascanio MD

Luca D’Ascanio MD

Department of Head and Neck Surgery, Institute of Otorhinolaryngology, Santa Croce Hospital AORMN, Fano-Pesaro, Italy

These authors contributed equally to this article.

Search for more papers by this author
Manlio Pandolfini MD

Manlio Pandolfini MD

Department of Head and Neck Surgery, Institute of Otorhinolaryngology, Santa Croce Hospital AORMN, Fano-Pesaro, Italy

Search for more papers by this author
Cristina Cingolani MD

Cristina Cingolani MD

Department of Head and Neck Surgery, Institute of Otorhinolaryngology, Santa Croce Hospital AORMN, Fano-Pesaro, Italy

Search for more papers by this author
Gino Latini MD

Gino Latini MD

Department of Head and Neck Surgery, Institute of Otorhinolaryngology, Santa Croce Hospital AORMN, Fano-Pesaro, Italy

Search for more papers by this author
Paolo Gradoni MD

Paolo Gradoni MD

Department of Head and Neck Surgery, Institute of Otorhinolaryngology, Santa Croce Hospital AORMN, Fano-Pesaro, Italy

Search for more papers by this author
Maria Capalbo

Maria Capalbo

AORMN, Pesaro, Italy

Search for more papers by this author
Gabriele Frausini MD

Gabriele Frausini MD

Internal Medicine Department “Santa Croce Hospital” AORMN, Fano, Italy

Search for more papers by this author
Massimo Maranzano

Massimo Maranzano

Division of Oral and Maxillofacial and Facial Plastic Surgery, Manchester University Foundation Trust, Manchester, UK

Search for more papers by this author
Michael J. Brenner MD

Corresponding Author

Michael J. Brenner MD

Department of Otolaryngology–Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA

These authors contributed equally to this article.

Michael J. Brenner, MD, Department of Otolaryngology–Head & Neck Surgery, University of Michigan Medical School, 1500 E. Medical Center Dr, 1903 Taubman Center SPC 5312, Ann Arbor, MI, 48109-5214, USA. Email: [email protected]Search for more papers by this author
Arianna Di Stadio MD, PhD

Arianna Di Stadio MD, PhD

Arianna Di Stadio, Department of Otolaryngology–Head & Neck Surgery, University of Perugia, Perugia, Italy

These authors contributed equally to this article.

Search for more papers by this author
First published: 14 July 2020
Citations: 53

Abstract

While olfactory dysfunction associated with coronavirus disease 2019 (COVID-19) has attracted considerable interest, few studies have tracked outcomes at serial time points or beyond 2 weeks. Furthermore, data are conflicting regarding whether COVID-19 severity correlates with degree of olfactory dysfunction. This prospective case-control study analyzed prevalence and severity of subjective loss of smell in outpatients (n = 23) and inpatients (n = 20) with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vs healthy controls (n = 25). Olfactory dysfunction was reported more commonly in COVID-19 patients than in healthy controls (P <. 001), and outpatients paradoxically reported loss of smell more commonly than inpatients (P =. 02). Headaches were present in 52% of patients with olfactory dysfunction. Anosmia or hyposmia persisted beyond 5 days but most of the patients recovered by 30 days, suggesting favorable prognosis for olfaction. Differences between inpatients and outpatients are potentially reflective of timeline of olfactory symptoms and contextual factors, underscoring the importance of corroborative objective testing, coupled with careful tracking of temporal relationships.